Latest Capital Structure News

Vectus Biosystems has posted a 58% drop in revenue and a 24% reduction in operating loss for FY2025, but its net equity has swung into negative territory.

Astron Limited has finalized its move from Hong Kong to Australia, issuing new securities on a two-for-one basis and preparing for ASX trading starting September 1, 2025.

Osteopore Limited reported a 6% increase in revenue to $1.56 million for the half-year ended June 2025, alongside a slight rise in net loss driven by expanded product development and compliance costs. The company secured key regulatory approvals and broadened its distribution footprint in Asia and the US.

Genmin Limited has increased insider loans by A$0.5 million, reinforcing funding for its flagship Baniaka iron ore project in Gabon as it targets production in late 2026.

Eden Innovations Ltd reported a 21% revenue increase driven by global sales growth, yet its net loss widened significantly due to prior year asset revaluations and ongoing operational costs. The company is undertaking major financial restructuring including a share consolidation and rights issue to stabilize its balance sheet.

Magontec Limited posted a 29% decline in revenue to $29.47 million for the first half of 2025, alongside a net loss of $3.96 million, while shutting down its Qinghai subsidiary. The results highlight ongoing challenges in the steel manufacturing sector.

Codeifai Limited reported a near doubling of its half-year loss to $3.93 million, alongside a 32% revenue drop, while pursuing transformative AI and quantum security acquisitions and securing $2.35 million in fresh capital.

Synertec Corporation has secured an additional A$4 million in debt funding from Altor Capital, expanding its total facility to A$19 million and reinforcing its financial position to support the expansion of its renewable microgrid technology.

EVE Health Group has reported a 19% decline in revenue and a 17% increase in net loss for the financial year ended June 2025, highlighting ongoing challenges in its health and wellness segments.

Senetas Corporation reported a substantial $27.8 million net profit for FY2025, driven by the strategic sale of its Votiro business. The company also announced plans for a capital return and a major share consolidation ahead of a promising growth outlook.

Senetas Corporation has reported a transformative FY2025 with a $27.8 million net profit driven by the divestment of its Votiro business, while its core network encryption operations remain profitable and cash generative.

Assetora Limited reported a reduced loss of $3.35 million for FY2025 despite an 18% revenue decline, focusing on capital raising and fund growth to stabilize operations.